PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 685 of 767

Advanced search
🇺🇸CDMOinvestors.emergentbiosolutions.comTier 2 · Direct publisher

Emergent BioSolutions to Participate in Upcoming Investor Conferences

Emergent BioSolutionsOriginal source
🌍Industryir.biolinerx.comTier 1 · Company source

BioLineRx to Report First Quarter 2026 Results on May 27, 2026

BioLineRxOriginal source
🇩🇪Researchuniklinikum-dresden.deTier 2 · Direct publisher

KIMed-Management-Board am ZMI

Universitätsklinikum DresdenOriginal source
🇺🇸Researchnews.emory.eduTier 2 · Direct publisher

‘Trouble the Land’ takes audiences on a multimedia journey through civil rights history | Emory University | Atlanta GA

Emory University School of MedicineOriginal source
🇩🇪Researchuniklinikum-dresden.deTier 2 · Direct publisher

BINGO! Spielen und unsere Patientinnen und Patienten unterstützen

Universitätsklinikum DresdenOriginal source
🌍Industryenanta.comTier 1 · Company source

Zelicapavir Reduces Symptom Duration and Hospitalization in a Randomized, Double-Blind, Placebo-Controlled, International, Phase 2 Trial

Enanta PharmaceuticalsOriginal source
🌍Regulatorytransceleratebiopharmainc.comTier 1 · Regulatory source

FDA Conversation on Selective Safety Data Collection

TransCelerate BioPharmaOriginal source
🌍Industryenanta.comTier 1 · Company source

EPS-3903 is a Potent and Selective Oral STAT6 Inhibitor That Blocks Th2 Inflammation in a House Dust Mite-Induced Asthma Mouse Model

Enanta PharmaceuticalsOriginal source
🌍Industryenanta.comTier 1 · Company source

EPS-3903, a Potent, Oral STAT6 Inhibitor, Exhibits Preferential Lung and Alveolar Macrophage Distribution with Low Drug–Drug Interaction Potential for the Treatment of Asthma

Enanta PharmaceuticalsOriginal source
🇺🇸Devicesbtig.comTier 1 · Company source

BTIG Expands Equity Derivatives Trading Team

BTIGOriginal source
🌍Regulatoryinfarma.plTier 1 · Regulatory source

W.A.I.T. Indicator: Polska awansuje o 3 miejsca i po raz pierwszy w historii jest powyżej średniej w Europie pod względem dostępu do innowacyjnych terapii

INFARMA PolandOriginal source
🌍Regulatoryinfarma.plTier 1 · Regulatory source

Pacjenci w Europie czekają dłużej na nowe leki, a nierówności między państwami członkowskimi rosną.

INFARMA PolandOriginal source
🌍Industrysignanthealth.comTier 1 · Company source

Signant Health Engages CNS Community at ASCP 2026

Signant HealthOriginal source
🇪🇺Regulatoryvaccineseurope.euTier 1 · Regulatory source

Vaccines as Global Health Security Infrastructure: Insights from a Descriptive Analysis of Vaccines Europe Members’ Clinical Pipelines

Vaccines EuropeOriginal source
🌍Mediascience37.comTier 2 · Direct publisher

Science 37 and Tufts CSDD Publish Landmark Study on Direct-to-Patient Clinical Trial Site Performance, Outperforming Industry Benchmarks

Science 37Original source
🇩🇪Researchuk-essen.deTier 2 · Direct publisher

Stellungnahme der Universitätsmedizin Essen zur aktuellen Berichterstattung rund um Prof. Kimmig und Schwangerschaftsabbrüche

Universitätsklinikum EssenOriginal source
🇺🇸Devicesir.idexx.comTier 1 · Company source

IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles

IDEXX LaboratoriesOriginal source
🌍Industryir.biolinerx.comTier 1 · Company source

BioLineRx and Hemispherian Announce New GLIX1 Data Demonstrating Potent Anti-Tumor Effect in Glioblastoma (GBM) Across Multiple In-Vivo Studies, Including a Temozolomide (TMZ)-Resistant Model with Patient-Derived Xenografts

BioLineRxOriginal source
🇩🇪Researchuniklinikum-dresden.deTier 2 · Direct publisher

Will

Universitätsklinikum DresdenOriginal source
🇺🇸Devicesnews.bostonscientific.comTier 1 · Company source

FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints

Boston Scientific NewsOriginal source
🇩🇪Researchuniklinikum-dresden.deTier 2 · Direct publisher

Lucelia

Universitätsklinikum DresdenOriginal source
🇩🇪Researchcharite.deTier 2 · Direct publisher

Charité, BIOTRONIK and German Heart Center Foundation Announce Partnership to Advance Digital Cardiology

Charité - Universitätsmedizin Berlin (EN)Original source
🇺🇸Industrybambusatx.comTier 1 · Company source

Bambusa Therapeutics Presents Positive Preliminary Phase 1 BBT002 Data at American Thoracic Society 2026 (ATS 2026) International Conference and Announces First Patient Dosed in Phase 1b/2a CRSwNP Trial

Bambusa TherapeuticsOriginal source
🇺🇸CDMOinvestors.emergentbiosolutions.comTier 2 · Direct publisher

Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]

Emergent BioSolutionsOriginal source
🇺🇸Devicesnews.bostonscientific.comTier 1 · Company source

Boston Scientific enters into $2 billion accelerated share repurchase agreement

Boston Scientific NewsOriginal source
🌍Industrynervgen.comTier 1 · Company source

NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates

NervGen PharmaOriginal source
🇫🇷Researchchu-lyon.frTier 2 · Direct publisher

Donner du lait : un geste simple pour sauver des vies

Hospices Civils de LyonOriginal source
🇫🇷Researchchu-lyon.frTier 2 · Direct publisher

Venez échanger sur les maladies inflammatoires chroniques de l'intestin (MICI)

Hospices Civils de LyonOriginal source
🇯🇵pharma_equipmentprodcms.ulvac.co.jpTier 2 · Direct publisher

Sales Termination of Oil Diffusion Ejector Pump PBL-02, 04, 06, 10, 14 and Water Cooling Baffle BW-2, 2・1/2

Ulvac (Pharma)Original source
🇸🇬Regulatoryapacmed.orgTier 1 · Regulatory source

From Concept To Practice: Advancing Regulatory Reliance For Medical Devices

APACMedOriginal source
🇫🇷Researchchu-lyon.frTier 2 · Direct publisher

Mai en gris : journée d'information sur les tumeurs cérébrales

Hospices Civils de LyonOriginal source
🇯🇵Researchmed.kyoto-u.ac.jpTier 2 · Direct publisher

Prof. Yukiko Mori has taken up her post in the Center for Digital Transformation of Healthcare

Kyoto University Faculty of MedicineOriginal source
🇺🇸Researchnews.emory.eduTier 2 · Direct publisher

What happens when AI clashes with religious belief?

Emory University School of MedicineOriginal source
🇺🇸Regulatoryciscrp.orgTier 1 · Regulatory source

Diversity in Dermatology Clinical Trials

CISCRP Patient InfoOriginal source
🇺🇸Industryfatetherapeutics.comTier 1 · Company source

Off-the-Shelf Anti-CD19 CAR T-cell Therapy With Reduced or No Conditioning Chemotherapy Demonstrates Efficacy and Tolerability in Systemic Lupus Erythematosus: Meaningful Activity Supports Planned Adolescent Enrollment

Fate TherapeuticsOriginal source
🇺🇸Industryfatetherapeutics.comTier 1 · Company source

FT839: A Multi-Antigen Targeting Off-the-Shelf Dual-CAR T Cell for the Treatment of Pathogenic B and T Cells in Autoimmune Diseases

Fate TherapeuticsOriginal source
🇺🇸Industryfatetherapeutics.comTier 1 · Company source

Safety and Efficacy of an Off-the-Shelf Anti-CD19 CAR T-Cell Therapy With Reduced Conditioning in SLE: A Phase 1 Study

Fate TherapeuticsOriginal source
🇺🇸CROcaidya.comTier 2 · Direct publisher

Trial Trends & Table Talk Event at OCT East Coast 2026

Caidya (Clinipace)Original source
🌍Regulatoryima.isTier 1 · Regulatory source

A new tariff for fees has come into effect

IMA IcelandOriginal source
🌍Researchpnas.orgTier 2 · Direct publisher

Ancient cyanobacteria repurposed plasmid DNA, perhaps opening the door to multicellularity

PNASOriginal source
🌍Industryrss.globenewswire.comTier 3 · Secondary coverage

ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update

ARS PharmaceuticalsOriginal source
🇺🇸Researchnews.emory.eduTier 2 · Direct publisher

Class serves up a taste of Shakespeare’s England | Emory University | Atlanta GA

Emory University School of MedicineOriginal source
🌍Industrycormedix.comTier 1 · Company source

CORMEDIX THERAPEUTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

CorMedixOriginal source
🇺🇸CROcaidya.comTier 2 · Direct publisher

IMP Release and Supply Management: Ensuring Compliance from Manufacture to Site

Caidya (Clinipace)Original source
🇺🇸Devicespathai.comTier 1 · Company source

PathAI’s AISight® Dx IMS Platform Supports the AISight Consults Workflow for Streamlined Digital Consult Management

PathAIOriginal source
🇺🇸Devicesviz.aiTier 1 · Company source

Viz.ai Launches Viz Pulmonary Suite, the First Comprehensive AI-Powered Solution Dedicated to Pulmonary Care Delivery

Viz.aiOriginal source
🇺🇸Devicesapyxmedical.comTier 1 · Company source

Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction

Apyx MedicalOriginal source
🌍Industrybenitec.comTier 1 · Company source

Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update

Benitec BiopharmaOriginal source
🌍Regulatoryravimiamet.eeTier 1 · Regulatory source

Disruptions may occur when sending e-mails to State Agency of Medicines contacts

SAM EstoniaOriginal source
🌍Industryrss.globenewswire.comTier 3 · Secondary coverage

GH Research Reports First Quarter 2026 Financial Results and Provides Business Update

GH ResearchOriginal source
🇺🇸Researchnews.emory.eduTier 2 · Direct publisher

Class of 2026 members reflect on their time at Emory | Emory University | Atlanta GA

Emory University School of MedicineOriginal source
🌍Industryaptose.comTier 1 · Company source

Aptose Reports First Quarter 2026 Results

Aptose BiosciencesOriginal source
🌍Regulatorycssp.gob.svTier 1 · Regulatory source

Principales Logros Consejo Directivo y JVPS período 2024-2026

Consejo Superior de Salud Pública (El Salvador)Original source
🌍Industryir.talphera.comTier 1 · Company source

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

TalpheraOriginal source
🌍Medianorstella.comTier 2 · Trade media

NorstellaLinQ: Identify obesity treatment opportunity before the market does

Norstella (Citeline + Evaluate + MMIT AI)Original source
🇺🇰Researchstemcells.cam.ac.ukTier 2 · Direct publisher

SCI-TIF community gathers for 4th Annual Networking Dinner

Cambridge Stem Cell InstituteOriginal source
🇺🇸CROir.criver.comTier 2 · Direct publisher

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

Charles River LaboratoriesOriginal source
🇯🇵Industrysumitomo-pharma.comTier 1 · Company source

Sumitomo Pharma Announces Personnel Changes

Sumitomo PharmaOriginal source
🌍Industrycibeles.com.uyTier 1 · Company source

GLIFOWEED PLATINUM

Cibeles (Uruguay)Original source
🌍Industryintercure.coTier 1 · Company source

3 (Initial insider holdings report)

InterCureOriginal source